AXA S.A. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.

Quarter-by-quarter ownership
AXA S.A. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$400,150
-42.4%
265,000
-4.6%
0.00%
-66.7%
Q4 2022$694,250
-70.4%
277,700
-50.0%
0.00%
-40.0%
Q3 2022$2,343,894
+165.4%
555,400
+1890.7%
0.01%
+66.7%
Q3 2018$883,000
-8.3%
27,900
+12.5%
0.00%
-25.0%
Q2 2018$963,000
+15.7%
24,800
-43.4%
0.00%0.0%
Q1 2016$832,000
-46.0%
43,820
-24.0%
0.00%
-42.9%
Q4 2015$1,540,00057,6600.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders